A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
Conditions:   Lymphoma;   Lymphoma, B-Cell;   Lymphoma, T-Cell;   Lymphoma, Hodgkin;   Lymphoma, Non-Hodgkin
Intervention:   Other: Pharmacokinetics
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments